Banner

Expression and prognostic significance of cyclin D1 and cyclooxygenase-2 in colorectal carcinoma: an immunohistochemical study

• 2022
Back
Publication Information
Authors Rania G. Roshdy, Eman M. Said
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type Local
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background
Colorectal cancer (CRC) is one of the most frequent cancers worldwide. Cyclin D1
(CNND1) and cyclooxygenase-2 (Cox-2) are expressed in a plethora of neoplastic
tissues.
Aim
The present work was conducted to examine the immunohistochemical expression
of CNND1 and Cox-2 in colorectal adenocarcinoma, compared with colonic
adenoma to evaluate its association with various clinicopathological features.
Patients and methods
A total of 30 colorectal adenocarcinoma cases, 20 cases of colonic adenoma, and
10 normal colonic mucosal biopsies as controls were studied. Immunohistochemical
technique was applied to detect CNND1 and Cox-2 expression and correlate them
with clinicopathological findings.
Results
Both cytoplasmic high CNND1 and nuclear positive Cox-2 expression were
significantly increased from normal colonic mucosa (0 and 10%, respectively)
to CRC (80 and 83.3%, respectively) passing through colon adenoma (25 and
55%, respectively) (P≤0.001 for both). High CNND1 score was significantly related
to lymph node spread and stage (P≤0.001 for both). A statistically significant
difference was documented between Cox-2 and grade of differentiation (P=0.017),
distant metastasis, and TNM stage (P=0.033, 0.003, respectively).
Conclusion
The present work suggests the oncogenic role of CNND1 and Cox-2 in CRC.
Furthermore, overexpressions of CNND1 and Cox-2 are associated with poor
prognostic factors, implicating their potentially prognostic role in CRC.